Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 6865-6869, November 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X.-Y.
Right arrow Articles by Ehrlich, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X.-Y.
Right arrow Articles by Ehrlich, M.

An MDBP Site in the First Intron of the Human c-myc Gene1

Xian-Yang Zhang, Prakash C. Supakar, Kezuo Wu, Kenneth C. Ehrlich and Melanie Ehrlich2

Department of Biochemistry, Tulane Medical School, New Orleans, Louisiana 70112 [X-Y. Z., P. C. S., K. W., M. E.], and Southern Regional Research Center, United States Department of Agriculture, New Orleans, Louisiana 70179 [K. C. E.]

The expression of the human c-myc protooncogene is subject to many levels and types of control. Evidence suggests that regulation of the expression of this gene involves elements within the gene as well as those upstream from the gene. We show that a ubiquitous mammalian sequence-specific DNA-binding protein, MDBP, binds specifically to a site in the beginning of the first intron of this gene. This protein, which binds to certain viral enhancers, may be helping to control expression of the c-myc gene. In some Burkitt lymphomas, which contain activated c-myc genes, the MDBP site is lost by chromosome rearrangement or by multiple spontaneous mutations. This might contribute to cancer-related activation of this protooncogene.

1 This work was supported by USPHS grant GM33999.

2 To whom requests for reprints should be addressed, at Department of Biochemistry, Tulane University School of Medicine, 1430 Tulane Ave., New Orleans, LA 70112.

Received 3/26/90. Accepted 7/24/90.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. K. Sengupta, M. Ehrlich, and B. D. Smith
A Methylation-responsive MDBP/RFX Site Is in the First Exon of the Collagen alpha 2(I) Promoter
J. Biol. Chem., December 17, 1999; 274(51): 36649 - 36655.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Chen, L. Smith, M. R. Johnson, K. Wang, R. B. Diasio, and J. B. Smith
Activation of Protein Kinase C Induces Nuclear Translocation of RFX1 and Down-regulates c-myc via an Intron 1 X Box in Undifferentiated Leukemia HL-60 Cells
J. Biol. Chem., October 6, 2000; 275(41): 32227 - 32233.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.